Patients suffering from androgenetic alopecia are to be treated with rosemary oil along with minoxidil 5 percent in one group, minoxidil 5 percent in another group and rosemary oil alone to compare the effect of the treatments in different groups in respect to reduction in hair loss.

Comparative evaluation of Effectiveness of Minoxidil 5 percent with Rosemary oil, Minoxidil 5 percent and Rosemary oil alone in the treatment of Androgenetic alopecia. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089089

Enrollment

Registered

2025-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L08- Infections of the skin and subcutaneous tissue

Interventions

Intervention1: ROSEMARY OIL: Rosemary oil inhibits 5alpha reductase to be intervened for one year duration. Control Intervention1: MINOXIDIL 5%: Approved for androgewnetic alopecia by FDA.

Eligibility

Inclusion criteria

Inclusion criteria: 1)Male patients between 18 yrs to 50 yrs of age. 2)Patients with AGA grade I-V of modified Hamilton Norwood Scale 3)Willing to give a written consent

Exclusion criteria

Exclusion criteria: 1)Patients taking Finasteride or any other medications for the treatment of AGA 2)Any dermatological diseases of scalp 3)History of use of Platelet rich plasma therapy in the past 4)Patients with existing neuro-psychiatric disorders & any other associated pre-existing medical illness like autoimmune conditions, thyroid disorder, iron deficiency anaemia, undergoing radiation therapy, malnutrition.

Design outcomes

Primary

Measure	Time frame
To study and compare decrease in hair loss in all the 3 groups. Timepoint: To study and compare decrease in hair loss in all the 3 groups.	—

Secondary

Measure	Time frame
1)To compare increase in hair growth in all 3 groups 2)To compare significant improvement in the duration of treatment required in all 3 groups 3)To compare scaling, dandruff, scalp itchingTimepoint: 15 days- for complaints 3 months- follow up 6 months- follow up 9 months- follow up 12 months- follow up	—

Countries

India

Contacts

Public ContactNatasha Biswas

SCB Medical college and hospital, Cuttack

drrashmita15@gmail.com9437268984

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026